149 related articles for article (PubMed ID: 33346093)
1. Early MRI Blood Volume Changes in Constrictor Muscles Correlate With Postradiation Dysphagia.
Mierzwa ML; Gharzai LA; Li P; Wilkie JR; Hawkins PG; Aryal MP; Lee C; Rosen B; Lyden T; Blakely A; Chapman CH; Thamarus J; Schonewolf C; Shah J; Eisbruch A; Schipper MJ; Cao Y
Int J Radiat Oncol Biol Phys; 2021 Jun; 110(2):566-573. PubMed ID: 33346093
[TBL] [Abstract][Full Text] [Related]
2. Correlating computed tomography perfusion changes in the pharyngeal constrictor muscles during head-and-neck radiotherapy to dysphagia outcome.
Truong MT; Lee R; Saito N; Qureshi MM; Ozonoff A; Romesser PB; Wang J; Sakai O
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):e119-27. PubMed ID: 21669502
[TBL] [Abstract][Full Text] [Related]
3. A prospective longitudinal assessment of MRI signal intensity kinetics of non-target muscles in patients with advanced stage oropharyngeal cancer in relationship to radiotherapy dose and post-treatment radiation-associated dysphagia: Preliminary findings from a randomized trial.
Joint Head and Neck Radiotherapy-MRI Development Cooperative
Radiother Oncol; 2019 Jan; 130():46-55. PubMed ID: 30206020
[TBL] [Abstract][Full Text] [Related]
4. Characterization of very late dysphagia after chemoradiation for oropharyngeal squamous cell carcinoma.
Gharzai LA; Li P; Schipper MJ; Yao J; Mayo CS; Wilkie JR; Hawkins PG; Lyden T; Blakely A; Ibrahim M; Schonewolf CA; Shah J; Eisbruch A; Casper K; Mierzwa M
Oral Oncol; 2020 Dec; 111():104853. PubMed ID: 32805634
[TBL] [Abstract][Full Text] [Related]
5. Influence of radiation dose to pharyngeal constrictor muscles on late dysphagia and quality of life in patients with locally advanced oropharyngeal carcinoma.
Mogadas S; Busch CJ; Pflug C; Hanken H; Krüll A; Petersen C; Tribius S
Strahlenther Onkol; 2020 Jun; 196(6):522-529. PubMed ID: 32006068
[TBL] [Abstract][Full Text] [Related]
6. Dysphagia after definitive radiotherapy for head and neck cancer. Correlation of dose-volume parameters of the pharyngeal constrictor muscles.
Deantonio L; Masini L; Brambilla M; Pia F; Krengli M
Strahlenther Onkol; 2013 Mar; 189(3):230-6. PubMed ID: 23319255
[TBL] [Abstract][Full Text] [Related]
7. Dysphagia and aspiration after chemoradiotherapy for head-and-neck cancer: which anatomic structures are affected and can they be spared by IMRT?
Eisbruch A; Schwartz M; Rasch C; Vineberg K; Damen E; Van As CJ; Marsh R; Pameijer FA; Balm AJ
Int J Radiat Oncol Biol Phys; 2004 Dec; 60(5):1425-39. PubMed ID: 15590174
[TBL] [Abstract][Full Text] [Related]
8. Identifying organs at risk for radiation-induced late dysphagia in head and neck cancer patients.
Hedström J; Tuomi L; Finizia C; Olsson C
Clin Transl Radiat Oncol; 2019 Nov; 19():87-95. PubMed ID: 31646203
[TBL] [Abstract][Full Text] [Related]
9. Dysphagia after chemoradiotherapy for head-and-neck squamous cell carcinoma: dose-effect relationships for the swallowing structures.
Dirix P; Abbeel S; Vanstraelen B; Hermans R; Nuyts S
Int J Radiat Oncol Biol Phys; 2009 Oct; 75(2):385-92. PubMed ID: 19553033
[TBL] [Abstract][Full Text] [Related]
10. Radiation-Associated Chronic Dysphagia Assessment by Flexible Endoscopic Evaluation of Swallowing (FEES) in Head and Neck Cancer Patients: Swallowing-Related Structures and Radiation Dose-Volume Effect.
Ozkaya Akagunduz O; Eyigor S; Kirakli E; Tavlayan E; Erdogan Cetin Z; Kara G; Esassolak M
Ann Otol Rhinol Laryngol; 2019 Feb; 128(2):73-84. PubMed ID: 30343589
[TBL] [Abstract][Full Text] [Related]
11. Late dysphagia after IMRT for head and neck cancer and correlation with dose-volume parameters.
Mortensen HR; Jensen K; Aksglæde K; Behrens M; Grau C
Radiother Oncol; 2013 Jun; 107(3):288-94. PubMed ID: 23791365
[TBL] [Abstract][Full Text] [Related]
12. Chemo-IMRT of oropharyngeal cancer aiming to reduce dysphagia: swallowing organs late complication probabilities and dosimetric correlates.
Eisbruch A; Kim HM; Feng FY; Lyden TH; Haxer MJ; Feng M; Worden FP; Bradford CR; Prince ME; Moyer JS; Wolf GT; Chepeha DB; Ten Haken RK
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):e93-9. PubMed ID: 21592678
[TBL] [Abstract][Full Text] [Related]
13. Dosimetric Predictors of Patient-Reported Xerostomia and Dysphagia With Deintensified Chemoradiation Therapy for HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
Chera BS; Fried D; Price A; Amdur RJ; Mendenhall W; Lu C; Das S; Sheets N; Marks L; Mavroidis P
Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1022-1027. PubMed ID: 28721884
[TBL] [Abstract][Full Text] [Related]
14. Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: Results of a prospective registry.
Kamal M; Mohamed ASR; Volpe S; Zaveri J; Barrow MP; Gunn GB; Lai SY; Ferrarotto R; Lewin JS; Rosenthal DI; Jethanandani A; Meheissen MAM; Mulder SL; Cardenas CE; Fuller CD; Hutcheson KA;
Radiother Oncol; 2018 Sep; 128(3):442-451. PubMed ID: 29961581
[TBL] [Abstract][Full Text] [Related]
15. Predictive modelling for swallowing dysfunction after primary (chemo)radiation: results of a prospective observational study.
Christianen ME; Schilstra C; Beetz I; Muijs CT; Chouvalova O; Burlage FR; Doornaert P; Koken PW; Leemans CR; Rinkel RN; de Bruijn MJ; de Bock GH; Roodenburg JL; van der Laan BF; Slotman BJ; Verdonck-de Leeuw IM; Bijl HP; Langendijk JA
Radiother Oncol; 2012 Oct; 105(1):107-14. PubMed ID: 21907437
[TBL] [Abstract][Full Text] [Related]
16. Long term patient reported swallowing function following chemoradiotherapy for oropharyngeal carcinoma.
Dixon L; Ramasamy S; Cardale K; Dyker K; Garcez K; Lee LW; McPartlin A; Murray P; Sen M; Slevin N; Sykes A; Prestwich R; Thomson D
Radiother Oncol; 2018 Sep; 128(3):452-458. PubMed ID: 29937211
[TBL] [Abstract][Full Text] [Related]
17. Dose-volume toxicity modeling for de-intensified chemo-radiation therapy for HPV-positive oropharynx cancer.
Mavroidis P; Price A; Fried D; Kostich M; Amdur R; Mendenhall W; Liu C; Das S; Marks LB; Chera B
Radiother Oncol; 2017 Aug; 124(2):240-247. PubMed ID: 28712533
[TBL] [Abstract][Full Text] [Related]
18. Beyond mean pharyngeal constrictor dose for beam path toxicity in non-target swallowing muscles: Dose-volume correlates of chronic radiation-associated dysphagia (RAD) after oropharyngeal intensity modulated radiotherapy.
MD Anderson Head and Neck Cancer Symptom Working Group
Radiother Oncol; 2016 Feb; 118(2):304-14. PubMed ID: 26897515
[TBL] [Abstract][Full Text] [Related]
19. Modeling Dose Response for Late Dysphagia in Patients With Head and Neck Cancer in the Modern Era of Definitive Chemoradiation.
Tsai CJ; Jackson A; Setton J; Riaz N; McBride S; Leeman J; Kowalski A; Happersett L; Lee NY
JCO Clin Cancer Inform; 2017 Nov; 1():1-7. PubMed ID: 30657398
[TBL] [Abstract][Full Text] [Related]
20. Evaluating predictive factors for toxicities experienced by head & neck cancer patients undergoing radiotherapy.
Ray X; Sumner W; Sutton L; Sanghvi P; Deichaite I; Moiseenko V
J Transl Med; 2021 Sep; 19(1):380. PubMed ID: 34493300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
